Parabolic Drugs informs about updates

22 Dec 2017 Evaluate

Parabolic Drugs has informed that with reference to e-mail dated 21-12-2017, in regard to deficiency observed in the financial result for the Quarter/Half year ended on 30th September, 2017 with respect to the point, Reconciliation of Profit and Loss not submitted.

The above information is a part of company’s filings submitted to BSE

Parabolic Drugs Share Price

1.05 0.00 (0.00%)
25-Jan-2021 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×